BioCentury
ARTICLE | Financial News

uniQure raises $128.5M follow-on

May 4, 2018 4:17 PM UTC

Gene therapy company uniQure N.V. (NASDAQ:QURE) raised $128.5 million on May 3 in a follow-on through the sale of 4.5 million shares at $28.50. Leerink Partners, Evercore ISI, Wells Fargo Securities, Chardan, H.C. Wainwright & Co. and Janney Montgomery Scott were underwriters.

The price is a 5% discount to uniQure’s close of $29.85 on May 1, when the company proposed after market hours to sell 4 million shares. uniQure gained $0.57 to $30.42 on May 2, and then slipped $1.28 to $29.14 on May 3...

BCIQ Company Profiles

uniQure N.V.

BCIQ Target Profiles

Factor IX